Skip to content
10-K

Annual Report

FORMA THERAPEUTICS HOLDINGS, INC.

0000950170-22-002527

← back to feed
Filed
Mar 1, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Feb 22, 2022 47.47M sh
Stock Issued FY 2021 · Dec 31, 2021 15.96M sh
Stock Issued FY 2021 · Dec 15, 2020 795K sh
Capex FY 2021 · Dec 31, 2021 $4.18M
Capex FY 2021 · Dec 31, 2020 $249K
Operating Cash Flow FY 2021 · Dec 31, 2021 −$149.79M
Operating Cash Flow FY 2021 · Dec 31, 2020 −$95.42M
Cash And Equivalents FY 2021 · Dec 31, 2021 $77.42M
Cash And Equivalents FY 2021 · Dec 31, 2020 $282.69M
Stockholders Equity FY 2021 · Dec 31, 2021 $498.36M
Stockholders Equity FY 2021 · Dec 31, 2020 $648.24M
Stockholders Equity FY 2021 · Dec 31, 2019 $18.25M
Current Liabilities FY 2021 · Dec 31, 2021 $35.09M
Current Liabilities FY 2021 · Dec 31, 2020 $31.7M
Total Liabilities FY 2021 · Dec 31, 2021 $62.71M
Total Liabilities FY 2021 · Dec 31, 2020 $32.73M
Current Assets FY 2021 · Dec 31, 2021 $486.4M
Current Assets FY 2021 · Dec 31, 2020 $654.45M
Total Assets FY 2021 · Dec 31, 2021 $561.06M
Total Assets FY 2021 · Dec 31, 2020 $680.97M
Sga Expense FY 2021 · Dec 31, 2021 $48.33M
Sga Expense FY 2021 · Dec 31, 2020 $30.78M
Rd Expense FY 2021 · Dec 31, 2021 $125.66M
Rd Expense FY 2021 · Dec 31, 2020 $93.37M
Net Income FY 2021 · Dec 31, 2021 −$172.96M
Net Income FY 2021 · Dec 31, 2020 −$70.41M
Operating Income FY 2021 · Dec 31, 2021 −$173.99M
Operating Income FY 2021 · Dec 31, 2020 −$124.21M
Revenue FY 2021 · Dec 31, 2021 $0
Revenue FY 2021 · Dec 31, 2020 $0